SSDC Consortium Agreement

Description of procurement item to be purchased: 2027 Sovereign States Drug Consortium Membership Dues. Estimated value of the contract/purchase order/increase: **$40,000**.

Utah is a member of the Sovereign States Drug Consortium. Members agree to share consortium costs evenly based on the number of participating states. The consortium allows states to receive better drug rebates than they would negotiating rebates alone, due to the larger number of covered lives when pooled together. Utah receives millions of dollars each year in drug rebates.

The consortium has a vendor that conducts administrative work and negotiates with drug manufacturers on the consortium's behalf. Vermont procures and pays the vendor as the agent state for the consortium. Consortium members meet virtually quarterly and has an annual in person meeting to discuss upcoming year rebates and industrial related topics. Each member state can choose whether to accept a rebate offer, and rebate agreements are signed individually by the participating states.

**Vendor:** State of Vermont Office of Health Access.

Membership in the Sovereign States Drug Consortium is only offered by said consortium. [...] This cannot be modified for competition as no one else can provide SSDC membership. The Medicaid State Plan, incorporated with the administrative rule, directs the state to participate in SSDC.

Any such vendors must submit the following information:

• The name of the contesting person; and
• A detailed explanation of the contest, including documentation showing that there are other competing sources for the procurement item.

Regardless of any prior communications with the Division of Purchasing or the State, all vendors interested in responding to this notice must submit a response to this posting containing complete responses to all of the information requested above.

**DO NOT CONTACT THE CONDUCTING PROCUREMENT UNIT.** Any questions regarding this notice, including obtaining additional information, can be obtained through the Division of Purchasing during the publication period. No action is required if you agree with this notice.